@ARTICLE{
author={Schwartzberg Lee Steven,Roeland E,Andric Zoran G,Kowalski Dariusz,Radic J,Voisin Daniel,Rizzi Giada,Navari R,Gralla Richard J,Karthaus Meinolf},
year={2018},
title={Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy},
journal={ANNALS OF ONCOLOGY},
volume={29},
number={7},
pages={1535-1540},
document_type={Article},
} 

@ARTICLE{
author={Bosnjak Snezana M,Stamatovic Ljiljana,Borroni Maria Elisa,Rizzi Giada,Jordan Karin},
year={2018},
title={Efficacy and Safety of Oral NEPA (Netupitant/Palonosetron), the First Fixed-Combination Antiemetic, in Patients With Gynecological Cancers Receiving Platinum-Based Chemotherapy},
journal={INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER},
volume={28},
number={6},
pages={1153-1161},
document_type={Article},
} 

@ARTICLE{
author={Aapro Matti,Jordan Karin,Gralla Richard J,Rizzi Giada,Rossi Giorgia,Palmas Marco,Alyasova Anna V,Lisyanskaya Alla S,Bosnjak Snezana M,Hesketh Paul J},
year={2017},
title={Safety and efficacy of NEPA, an oral fixed combination of netupitant and palonosetron, in older patients},
journal={JOURNAL OF GERIATRIC ONCOLOGY},
volume={8},
number={1},
pages={56-63},
document_type={Article},
} 

@ARTICLE{
author={Gralla RJ,Bosnjak Snezana M,Hontsa A,Balser C,Rizzi Giada,Rossi G,Borroni Maria Elisa,Jordan Karin},
year={2014},
title={A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy},
journal={ANNALS OF ONCOLOGY},
volume={25},
number={7},
pages={1333-1339},
document_type={Article},
}